3NHD | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | ACY | enzyme |
| ||||||||||||
Primary reference | Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease., Apostol MI, Sawaya MR, Cascio D, Eisenberg D, J Biol Chem. 2010 Sep 24;285(39):29671-5. Epub 2010 Aug 4. PMID:20685658 |
Data retrieval |
![]() |
View 3NHD in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |